HemoCept
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, HemoCept sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
HemoCept: 4 sponsored US clinical trials, 2 recruiting.
HemoCept sponsors 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Aortic Valve Stenosis, with 1 trials.
Upper-quartile sponsor footprint
HemoCept sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
NCT07224906
Detecting Changes in Arterial Blood Volume and Cardiac Efficiency
NCT07205341
Fluid Status of ESRD Patients Undergoing Dialysis
NCT07217470
Fluid Status of Dialysis Subjects
NCT07217041
Therapeutic Areas
What is open in the HemoCept pipeline
2 recruiting of 4 indexed (50% open); 2 completed (50%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Aortic Valve Stenosis (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
HemoCept: open-pipeline peers nationwide
Peers matched on 4 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
HemoCept sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 7 Hills Pharma · 50% recruiting · 2 trials
Related
What to do with this HemoCept page
4 registered trials is a research-attention snapshot, not an endorsement of HemoCept or any single study.
- 2 of HemoCept's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Aortic Valve Stenosis is the condition HemoCept studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aortic Valve Stenosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
HemoCept pipeline card: 4 registered trials from official public datasets.Report a data error.